Ningbo Traditional Chinese Pharmaceutical Corp. announced that it has entered into share issuance subscription contract with Zhejiang Huakang Pharmaceutical Co., Ltd. to subscribe for 8,518,000 shares at a price of CNY 2.58 for gross proceeds of CNY 21,976,440 on January 6, 2022. The transaction is within the approval authority of the general manager's office meeting, and does not need to be submitted to the company's board of directors and shareholders' meeting for consideration and has been approved by the general meeting of shareholders of company and has obtained the no-objection certificate issued by the National Equities Exchange and Quotations Company for this stock issuance. effective after the letter.

On March 10, 2022, the company announced that it has received no objection to the directional issuance of shares, which is valid for 12 months.